The recent advancements in the application of Artificial Intelligence (AI) to analyse large data sets are changing the methods of research and personalisation of medicine. With whole-genome sequencing and the digitisation of patient records, large data sets have become available and AI applications can quickly and easily examine, organise and reference a patient’s unique molecular and physiological profile. Through AI analytical tools and machine learning models, we will be able to more accurately diagnose diseases and create the perfect prescription personalised to a patient’s genetic makeup.
Johnson & Johnson Innovation – JLABS and the Innovation Forum would like to invite you to an engaging discussion around how AI will make an impact on various aspects of healthcare, including diagnosis, drug discovery, patient engagement, caregivers and more.
